Tag Archive for: TAP

Online seminar recording: Functional Tartaric Acid Pellets in Modern Formulation Challenges

Apr 05, 2022. Register for the online seminar recordings: “Functional Tartaric Acid Pellets in Modern Formulation Challenges”.
Speakers: Philippe Tschopp, Raja Subburayalu, with kind session chair by Marco Resciniti.
Sponsoring companies: Glatt GroupingredientpharmPHARMATRANS SANAQ AGHARKE GROUP.
Target group: for Manager working in Pharmaceutical Technology and Formulation Sciences.

Register here: Webinar-Registrierung – Zoom

Functional Tartaric Acid Pellets in Modern Formulation Challenges

Abstract: Functional Tartaric Acid Pellets in Modern Formulation Challenges

Multi particulate modified release dosage forms, where the drug shows pH dependent solubility, require an acidic in-situ microenvironment to improve solubility, release, and absorption. Present generic formulations focus on these so-called BSC Class IV drugs. The Role of Reverse Engineering is thereby an efficient key tool in the development of generic formulations. A Case study presents latest state-of-the-art achievements.

Expert presenters

The live webcast will bring interesting case provided by Pharmatrans SANAQ® and technically discussed and presented by Philippe Tschopp, Business Development at Glatt Pharmaceutical Services in Germany and Dr. Raja Subburayalu, consultant in Manufacturing Science and Technology Transfer for Zydus Cadila Healthcare Limited, based in Ahmedabad, Gujarat, India.

Reverse Engineering

Dr Subburayalu will explore how present generic formulations focus on so-called BSC Class IV drugs in which multi particulate modified release dosage forms, where the drug shows pH dependent solubility, require an acidic in-situ microenvironment to improve solubility, release, and absorption.

They will highlight how Reverse Engineering using TAP® can form an efficient key tool in the development of generic formulations. The webinar will feature a case study illustrating latest state-of-the-art achievements.

Register here for the online seminar recording

Webinar-Registrierung – Zoom

 

TAP Registration for Chinese Market

TAP Registration for Chinese Market

ingredientpharm announces that TAP Registration for Chinese Market is approved. The new Drug Master File for TAP® following ChP regulations enables to use drug formulations containing TAP® to be marketed in one of the world largest pharmaceutical markets.

TAP® is a pelletized excipient made of 100% Tartaric Acid. These functional pellets modify the local environment and increase the solubility of BSC Class IV drugs tremendously. TAP® pellets are available in different sizes from 100 µm to 1000 µm and corresponds to monographs Ph.Eur., USP/NF, JP/JPE, ChP.

See: product details

TAP® Registration for Chinese Market